10-year trend analysis of atrioventricular node ablation in patient with atrial fibrillation: 2005–2014 United State hospitalization

Abstract Introduction Atrial fibrillation (AF) ablation and Atrioventricular Node (AVN) ablation are both important non-pharmacological therapy of AF. In spite of increased availability of AF ablation data, that of AVN ablation per se is limited. Method AF ablation was identified using ICD-9 procedu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2020-11, Vol.41 (Supplement_2)
Hauptverfasser: Wu, L, Narasimhan, B, Shah, A.N, Zheng, Y.Y, Bhatia, K, Kantharia, B
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction Atrial fibrillation (AF) ablation and Atrioventricular Node (AVN) ablation are both important non-pharmacological therapy of AF. In spite of increased availability of AF ablation data, that of AVN ablation per se is limited. Method AF ablation was identified using ICD-9 procedure code with principle diagnosis of AF from United States National Inpatient Sample database 2005–2014. From procedure and diagnosis codes of pacemaker insertion followed by ablation, the cohort who underwent AVN ablation was identified. Patients hospitalization with any diagnosis of other type of arrythmia or epicardial ablation were excluded. Complications were defined as per the Agency for Health Care Research and Quality guideline. Results Total AF ablation was noted to increase from 2005- 2011, and declined steadily from 2011–2014. In contrast, the number of AVN ablations increased from 4505 cases to 5175 (Figure 1). AVN ablation were mainly performed in elderly patient (mean age 72), and increasingly in patient with higher Charlson Commobidity index (0.9 to 1.7)and higher CHA2DS2-VASc score (2.8 to 3.7) (Table 1). An increasing trend in procedure complications but no significant change in mortalitywere observed with AVN ablation. Progressive increase in the length of stay and the hospitalization cost were also observed over the years with AVN ablation. Conclusion AVN ablation is being performed at a steady volume, and increasingly in patients with multiple comorbidities. This trend although was not associated with increased mortality, it was associated with increased hospital complications. Table 1. Baseline characteristics and outcomes of AVN ablation 2005–2014 Variable Year Trend p value 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 AF ablation 9898 10078 11384 17611 14468 14526 19349 18330 16864 11735 0.004 AVN ablation 4505 6309 5438 6144 6628 5561 6505 6545 6169 5175 0.007 Mean age, years 72.05 72.63 72.54 72.26 72.32 72.40 72.64 72.67 72.67 72.87 0.128 Female, % 54.8 54.5 53.2 54.5 53.3 55.1 53.7 53.8 55.6 57.3 0.585 Mean Charlson index 0.90 1.02 1.17 1.22 1.30 1.37 1.32 1.47 1.54 1.69
ISSN:0195-668X
1522-9645
DOI:10.1093/ehjci/ehaa946.0549